Delivery Order SPE2DB20D3103-SPE2DB25FQ0E2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,067.06 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles). The contract employs firm fixed-price terms with an ultimate completion date of June 18, 2025, and was awarded on June 17, 2025, without set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,318.60 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100 count units). The contract is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025, awarded on July 30, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.02 to AmerisourceBergen Drug Corp for Methylphenidate ER 54 mg tablets (100-count units) on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.94 to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100 count) on July 23, 2025, with completion scheduled for July 24, 2025. This competitive, non-set-aside award represents a firm fixed-price delivery order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Methylphenidate ER (extended-release) tablets at 54mg dosage. This firm fixed-price delivery order, valued at $6,673.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,056.81 for Methylphenidate ER 54 mg tablets (100-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $5,234.78 by the Defense Logistics Agency (DLA) for the supply of Methylphenidate ER 27 mg tablets in quantities of 100 units per bottle. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 18, 2025. The award carries no set-aside designation, indicating the contract was competed among all eligible vendors. This delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100 count) valued at $2,856.60. This non-competitive, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0E2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,834.01 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles). This firm fixed-price, competitively awarded contract was issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in comprehensive medical supply procurement for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the DLA covering a broad spectrum of pharmaceutical products, including neurological treatments, pain management medications, diabetes drugs, antibiotics, vaccines, and specialized medical supplies. As a primary pharmaceutical provider to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen demonstrates the capability to fulfill diverse medical supply requirements through competitive procurement processes. This delivery order for methylphenidate, a controlled medication used in ADHD treatment, supports ongoing pharmaceutical needs within the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 8/26/25 |